title: In vitro activity of daptomycin against Enterococcus faecalis under various conditions of growth-phases, inoculum and pH.
abstract: Enterococcus faecalis (E. faecalis) has become a major leading cause of nosocomial endocarditis. Treatment of such infections remains problematic and new therapeutic options are needed. Nine E. faecalis strains were tested: six obtained from patients presenting endocarditis, one with isolated bacteremia, and two reference strains. Antibiotics included daptomycin, alone or in combination, linezolid, tigecycline, rifampicin, gentamicin, teicoplanin, ceftriaxone and amoxicillin. Time-kill studies included colony counts at 1, 4 and 24 h of incubation. Significant bactericidal activity was defined as a decrease of ≥3log10CFU/ml after 24 h of incubation. Antibiotics were tested at a low (10(6) CFU/ml) and high (10(9) CFU/ml) inoculum, against exponential- and stationary-phase bacteria. We also performed time kill studies of chemically growth arrested E. faecalis. Various pH conditions were used during the tests. In exponential growth phase and with a low inoculum, daptomycin alone at 60 µg/ml and the combination amoxicillin-gentamicin both achieved a 4-log10 reduction in one hour on all strains. In exponential growth phase with a high inoculum, daptomycin alone was bactericidal at a concentration of 120 µg/ml. All the combinations tested with this drug were indifferent. In stationary phase with a high inoculum daptomycin remained bactericidal but exhibited a pH dependent activity and slower kill rates. All combinations that did not include daptomycin were not bactericidal in conditions of high inoculum, whatever the growth phase. The results indicate that daptomycin is the only antibiotic that may be able of overcoming the effects of growth phase and high inoculum.
authors.affiliation: Infectious Diseases Department, Strasbourg University Hospital, Strasbourg, France. xavier_argemi@hotmail.com
authors.forename: Xavier
authors.initials: X
authors.lastname: Argemi
authors.forename: Yves
authors.initials: Y
authors.lastname: Hansmann
authors.forename: Daniel
authors.initials: D
authors.lastname: Christmann
authors.forename: Sophie
authors.initials: S
authors.lastname: Lefebvre
authors.forename: Benoit
authors.initials: B
authors.lastname: Jaulhac
authors.forename: François
authors.initials: F
authors.lastname: Jehl
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D017576:Daptomycin / Q000494:pharmacology*; D013293:Enterococcus faecalis / Q000187:drug effects* / Q000254:growth & development*; D006863:Hydrogen-Ion Concentration; D008826:Microbial Sensitivity Tests
chemical_list: D000900:Anti-Bacterial Agents; D017576:Daptomycin